Compare Nuvation Bio Inc. Class A Common Stock (NUVB) vs XPO Inc. Common Stock (XPO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuvation Bio Inc. Class A Common Stock vs XPO Inc. Common Stock — how do they compare? Nuvation Bio Inc. Class A Common Stock trades at $4.95 (market cap $1.74B), while XPO Inc. Common Stock trades at $179.79 (market cap $21.30B). The key difference: XPO Inc. Common Stock is far larger — about 12.2× Nuvation Bio Inc. Class A Common Stock's market cap, and XPO Inc. Common Stock is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Nuvation Bio Inc. Class A Common Stock for 0 Days and XPO Inc. Common Stock for 0 Days on average.
| NUVB | XPO | |
|---|---|---|
Market Cap | $1.74B | $21.30B |
Volume | 9,289,619 | 897,705 |
Sector | Health | Industrials |
52-Week High | $9.54 | $228.37 |
52-Week Low | $3.41 | $123.66 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $1.33B | $24.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →About XPO Inc. Common Stock
XPO provides freight transportation services in North America and Europe. Its operations include less-than-truckload freight transportation and brokerage services supported by a technology platform.
Read more on XPO →
